This is a preview of subscription content, log in via an institution to check access.
References
Kunutsor SK, Apekey TA, Steur M (2013) Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol. 2013;28(3):205–21.
Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012;175(1):66–73.
Bhandari SK, Pashayan S, Liu IL, Rasgon SA, Kujubu DA, Tom TY, et al. 25-hydroxyvitamin D levels and hypertension rates. J Clin Hypertens (Greenwich). 2011;13(3):170–7.
Khader YS, Batieha A, Jaddou H, Batieha Z, El-Khateeb M, Ajlouni K. Relationship between 25-hydroxyvitamin D and metabolic syndrome among Jordanian adults. Nutr Res Pract. 2011;5(2):132–9.
Pacifico L, Anania C, Osborn JF, Ferraro F, Bonci E, Olivero E, et al. Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol. 2011;165(4):603–11.
Caro Y, Negron V, Palacios C. Association between vitamin D levels and blood pressure in a group of Puerto Ricans. P R Health Sci J. 2012;31(3):123–9.
Dorjgochoo T, Ou Shu X, Xiang YB, Yang G, Cai Q, Li H, et al. Circulating 25-hydroxyvitamin D levels in relation to blood pressure parameters and hypertension in the Shanghai Women’s and Men’s Health Studies. Br J Nutr. 2012;108(3):449–58.
Kim S, Lim J, Kye S, Joung H. Association between vitamin D status and metabolic syndrome risk among Korean population: based on the Korean National Health and Nutrition Examination Survey IV-2, 2008. Diabetes Res Clin Pract. 2012;96(2):230–6.
Lee SH, Kim SM, Park HS, Choi KM, Cho GJ, Ko BJ et al. (2012) Serum 25-hydroxyvitamin D levels, obesity and the metabolic syndrome among Korean children. Nutr Metab Cardiovasc Dis. doi:10.1016/j.numecd.2012.04.013.
Li L, Yin X, Yao C, Zhu X, Wu X. Vitamin D, parathyroid hormone and their associations with hypertension in a Chinese population. PLoS ONE. 2012;7(8):e43344.
Nam GE, Kim DH, Cho KH, Park YG, Han KD, Kim SM et al. (2012) 25-Hydroxyvitamin D insufficiency is associated with cardiometabolic risk in Korean adolescents: the 2008-2009 Korea National Health and Nutrition Examination Survey (KNHANES). Public Health Nutr. 1–9. doi:10.1017/S1368980012004855.
Park HY, Lim YH, Kim JH, Bae S, Oh SY, Hong YC. Association of serum 25-hydroxyvitamin D levels with markers for metabolic syndrome in the elderly: a repeated measure analysis. J Korean Med Sci. 2012;27(6):653–60.
Sumriddetchkajorn K, Chailurkit L, Thakkinstian A, Sritara P. Hypertension is statistically associated with higher body mass index but not with vitamin D level in a Thai population. Eur J Clin Nutr. 2012;66(3):405–7.
Wang L, Ma J, Manson JE, Buring JE, Gaziano JM, Sesso HD (2012) A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men. Eur J Nutr. doi:10.1007/s00394-012-0480-8.
Burgaz A, Orsini N, Larsson SC, Wolk A (2011) Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 29(4):636–5.
Conflict of interest
None
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
See Fig. 4.
The dose–response analysis between circulating 25-hydroxyvitamin D [25(OH) D] levels and hypertension risk with restricted cubic splines in a multivariate random-effects dose–response model in cross-sectional studies. The solid line and the long dash line represent the estimated relative risk and its 95 % confidence interval. Short dash line represents the linear relationship
Rights and permissions
About this article
Cite this article
Wu, Y., Li, S. & Zhang, D. Circulating 25-hydroxyvitamin D levels and hypertension risk. Eur J Epidemiol 28, 611–616 (2013). https://doi.org/10.1007/s10654-013-9817-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-013-9817-8